XML 37 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Shareholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of summarizes the outstanding warrants

The following table summarizes the Company’s outstanding warrants as of March 31, 2025 and December 31, 2024:

 

 

 

Number of Warrant ADSs

 

 

 

 

 

 

 

 

March 31,

 

 

December 31,

 

 

Weighted-Average

 

 

 

 

 

2025

 

 

2024

 

 

Exercise Price

 

 

Expiration Date

Equity-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

October 2023 Investor Prefunded
   Warrants

 

 

48,387

 

 

 

48,387

 

 

$

0.20

 

 

None

March 2025 Series A Investor Warrants

 

 

2,283,031

 

 

 

 

 

$

0.87

 

 

3/6/2026

March 2030 Series B Investor Warrants

 

 

2,283,031

 

 

 

 

 

$

0.87

 

 

3/6/2030

May 2024 Investor Warrants

 

 

4,029,754

 

 

 

4,029,754

 

 

$

1.77

 

 

May-Jun 2027

March 2024 Placement Agent Warrants

 

 

132,061

 

 

 

132,061

 

 

$

1.85

 

 

3/27/2029

May 2024 Placement Agent Warrants

 

 

322,380

 

 

 

322,380

 

 

$

1.89

 

 

5/31/2029

November 2024 Investor Warrants

 

 

1,713,402

 

 

 

1,713,402

 

 

$

2.26

 

 

Dec 2027-Jun 2028

October 2023 Placement Agent Warrants

 

 

42,550

 

 

 

42,550

 

 

$

4.13

 

 

10/6/2028

March 2022 Investor Warrants

 

 

186,007

 

 

 

186,007

 

 

$

28.00

 

 

3/10/2027

March 2022 Placement Agent Warrants

 

 

14,874

 

 

 

14,874

 

 

$

30.00

 

 

3/10/2027

December 2021 Investor Warrants

 

 

107,775

 

 

 

107,775

 

 

$

33.00

 

 

1/4/2027

December 2021 Placement Agent
   Warrants

 

 

8,615

 

 

 

8,615

 

 

$

35.00

 

 

12/29/2026

2020 Investor Warrants

 

 

 

 

 

139,882

 

 

$

44.00

 

 

Feb-Mar 2025

July 2021 Placement Agent Warrants

 

 

19,909

 

 

 

19,909

 

 

$

46.40

 

 

7/7/2026

2020 Placement Warrants

 

 

 

 

 

22,481

 

 

$

51.00

 

 

Feb-Mar 2025

 

 

11,191,776

 

 

 

6,788,077

 

 

 

 

 

 

Liability-classified Warrants

 

 

 

 

 

 

 

 

 

 

 

April 2023 Peak Bio Warrants

 

 

1,187,013

 

 

 

1,187,013

 

 

$

2.04

 

 

4/28/2028

September 2022 Series B Investor Warrants

 

 

754,997

 

 

 

754,997

 

 

$

17.00

 

 

9/14/2029

November 2022 Peak Bio Warrants

 

 

1,577,556

 

 

 

1,577,556

 

 

$

39.18

 

 

11/1/2027

 

 

3,519,566

 

 

 

3,519,566

 

 

 

 

 

 

Total outstanding warrants

 

 

14,711,342

 

 

 

10,307,643

 

 

 

 

 

 

 

The following table summarizes the Company’s warrants activity for the three months ended March 31, 2025:

 

 

 

Number of

 

 

Weighted-Average

 

 

 

Warrants

 

 

Exercise Price

 

Outstanding at December 31, 2024

 

 

10,307,643

 

 

$

10.37

 

Issued

 

 

4,566,062

 

 

 

0.87

 

Exercised

 

 

 

 

 

 

Expired

 

 

(162,363

)

 

 

44.97

 

Outstanding at March 31, 2025

 

 

14,711,342

 

 

$

7.04